|
Sep 10
|
Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
|
|
Jun 27
|
New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
|
|
Jun 25
|
Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
|
|
Jun 20
|
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
|
|
Jun 5
|
We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation
|
|
May 6
|
Cathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough Of
|
|
May 6
|
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
|
|
May 2
|
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
|
|
May 2
|
10x Genomics First Quarter 2024 Earnings: In Line With Expectations
|
|
May 1
|
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Q1 2024 10X Genomics Inc Earnings Call
|
|
May 1
|
10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...
|
|
Apr 30
|
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Apr 30
|
10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches
|
|
Apr 30
|
10x Genomics Reports First Quarter 2024 Financial Results
|
|
Apr 29
|
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
|
|
Apr 26
|
3 Medical Products Stocks Set to Beat This Earnings Season
|
|
Apr 25
|
11 Oversold MidCap Stocks To Buy Now
|
|
Apr 24
|
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
|
|
Apr 23
|
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
|